A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
Crossref DOI link: https://doi.org/10.1007/s40119-016-0066-2
Published Online: 2016-07-25
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pinyol, Carme http://orcid.org/0000-0002-1532-0782
Cepeda, Jose MÂȘ
Roldan, Inmaculada
Roldan, Vanesa
Jimenez, Silvia
Gonzalez, Paloma
Soto, Javier
Funding for this research was provided by:
Pfizer